
Replimune, Inc.
UnclaimedPharmaceutical Preparation ManufacturingWoburn, MA
Founded
2015
Primary NAICS
325412
CAGE code
12X10
Federal awards
—
Overview
Replimune is a commercial-stage biotech company revolutionizing cancer treatment with a new class of oncolytic immunotherapies designed to activate a…
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Drugs and Biologicals